Using case examples, the session will be an interactive discussion to share learnings and the impact of the use of drug repurposing from different end users such as industry and academia with input from regulators, patients and HTA representatives.
Learning Objectives
To gain further insight on drug repurposing and share lessons learnt so far based on case examples. To identify what could be opportunities using repurposing for rare diseases. To share what has been done as part of the pilot on repurposing initiated by EMA at the end of 2021.
Chair
Solange Corriol-Rohou, DrMed, MD, PhD
Wednesday June 18, 2025 1:00pm - 1:30pm EDT TBDWalter E. Washington Convention Center 801 Allen Y. Lew Place, NW Washington, DC 20001-3614 USA
